Johnson & Johnson
US ˙ NYSE ˙ US4781601046

SecurityJNJ / Johnson & Johnson
InstitutionCapital Advantage, Inc.
Latest Disclosed Ownership5,339 shares
Latest Disclosed Value $ 1,305,143
Capital Advantage, Inc. reports 0.37% decrease in ownership of JNJ / Johnson & Johnson

On April 10, 2026 - Capital Advantage, Inc. filed a 13F-HR form disclosing ownership of 5,339 shares of Johnson & Johnson (US:JNJ) valued at $1,305,065 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 5,359 shares of Johnson & Johnson. This represents a change in shares of -0.37% during the quarter. The current value of the position is $1,191,878 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F JOHNSON & JOHNSON COM 478160104 5,339 -20 -0.37 1,305 17.67 0.1706
2026-01-07 2025-12-31 13F JOHNSON & JOHNSON COM 478160104 5,359 590 12.37 1,109 25.45 0.1496
2025-10-22 2025-09-30 13F JOHNSON & JOHNSON COM 478160104 4,769 7 0.15 884 21.60 0.1330
2025-07-11 2025-06-30 13F JOHNSON & JOHNSON COM 478160104 4,762 -148 -3.01 727 2.39 0.1152
2025-04-10 2025-03-31 13F JOHNSON & JOHNSON COM 478160104 4,910 0 0.00 710 0.00 0.1294
2025-02-14 2024-12-31 13F JOHNSON & JOHNSON COM 478160104 4,910 4,910 710 0.1294
2021-08-16 2021-06-30 13F Johnson & Johnson Com 478160104 0 -6,228 -100.00 0 -100.00
2021-04-26 2021-03-31 13F Johnson & Johnson Com 478160104 6,228 244 4.08 1,023 8.03 0.2788
2021-02-17 2020-12-31 13F Johnson & Johnson COM 478160104 5,984 101 1.72 947 8.85 0.2822
2020-11-12 2020-09-30 13F Johnson & Johnson COM 478160104 5,883 -119 -1.98 870 3.08 0.2864
2020-08-13 2020-06-30 13F Johnson & Johnson COM 478160104 6,002 -303 -4.81 844 -11.90 0.2998
2020-05-08 2020-03-31 13F Johnson & Johnson COM 478160104 6,305 138 2.24 958 4.70 0.3742
2020-02-14 2019-12-31 13F Johnson & Johnson COM 478160104 6,167 -100 -1.60 915 12.82 0.2893
2019-11-12 2019-09-30 13F Johnson & Johnson COM 478160104 6,267 -732 -10.46 811 -17.08 0.2808
2019-05-10 2019-03-31 13F Johnson & Johnson COM 478160104 6,999 -961 -12.07 978 -4.77 0.3473
2019-02-07 2018-12-31 13F Johnson & Johnson COM 478160104 7,960 48 0.61 1,027 -6.04 0.3894
2018-11-01 2018-09-30 13F Johnson & Johnson COM 478160104 7,912 -1,524 -16.15 1,093 -4.54 0.2511
2018-08-01 2018-06-30 13F Johnson & Johnson COM 478160104 9,436 394 4.36 1,145 -1.21 0.2698
2018-05-02 2018-03-31 13F Johnson & Johnson COM 478160104 9,042 -889 -8.95 1,159 -16.50 0.2835
2018-02-13 2017-12-31 13F Johnson & Johnson COM 478160104 9,931 -395 -3.83 1,388 3.35 0.3578
2017-10-30 2017-09-30 13F Johnson & Johnson COM 478160104 10,326 -29 -0.28 1,343 -1.97 0.3360
2017-08-08 2017-06-30 13F Johnson & Johnson COM 478160104 10,355 73 0.71 1,370 6.95 0.3590
2017-05-03 2017-03-31 13F Johnson & Johnson COM 478160104 10,282 518 5.31 1,281 13.87 0.3509
2017-02-01 2016-12-31 13F Johnson & Johnson COM 478160104 9,764 -42 -0.43 1,125 -2.85 0.3258
2016-11-02 2016-09-30 13F Johnson & Johnson COM 478160104 9,806 198 2.06 1,158 -0.60 0.3248
2016-08-10 2016-06-30 13F Johnson & Johnson COM 478160104 9,608 52 0.54 1,165 12.67 0.3384
2016-05-23 2016-03-31 13F Johnson & Johnson COM 478160104 9,556 -25 -0.26 1,034 5.08 0.3667
2016-02-26 2015-12-31 13F Johnson & Johnson COM 478160104 9,581 305 3.29 984 13.63 0.3317
2015-10-23 2015-09-30 13F Johnson & Johnson COM 478160104 9,276 840 9.96 866 5.35 0.3374
2015-08-14 2015-06-30 13F Johnson & Johnson COM 478160104 8,436 -161 -1.87 822 -4.97 0.3205
2015-05-15 2015-03-31 13F Johnson & Johnson COM 478160104 8,597 5 0.06 865 -3.67 0.3550
2015-05-15 2014-12-31 13F Johnson & Johnson COM 478160104 8,592 375 4.56 898 2.51 0.3703
2016-06-21 2014-09-30 13F Johnson & Johnson COM 478160104 8,217 -73 -0.88 876 1.04 0.4567
2016-07-15 2014-06-30 13F Johnson & Johnson COM 478160104 8,290 24 0.29 867 6.77 0.4784
2016-08-09 2014-03-31 13F Johnson & Johnson COM 478160104 8,266 702 9.28 812 17.17 0.5656
2016-08-24 2013-12-31 13F Johnson & Johnson COM 478160104 7,564 7,564 693 0.4657
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.